The Food and Drug Administration was allowed to participate in the World Health Organization's meeting this week on updating influenza shots, officials for the U.N. agency said, despite an order by President Trump last month banning government employees from working with the WHO. The administration has granted some exemptions to the order.

Flu vaccine makers may face a last-minute scramble to produce enough doses after an FDA advisory committee meeting was abruptly canceled.

This week, the Food and Drug Administration — now with vaccine skeptic Robert F. Kennedy Jr. at the helm — unexpectedly and without reason canceled a March meeting of scientists who advise the FDA on vaccine policy. A similar meeting at the Centers for Disease Control was postponed last week.

The meeting cancellation came one day before the CDC issued its weekly MMWR report, a scientific update on the latest public-health news. In the Feb. 27 edition, CDC scientists published new data on the benefits of flu shots in protecting both children and adults from serious complications.

The Food and Drug Administration has canceled an annual advisers meeting to weigh in on yearly updates to the flu vaccine, raising some experts' concerns about next year's shot. CBS News chief medical correspondent Dr.

The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13.

The Vaccines and Related Biological Products Advisory Committee was supposed to meet on March 13 to recommend to the agency which flu strains should be included in influenza shots for the Northern Hemisphere’s next flu season.